Dipartimento Scienze Della Salute Della Donna, Del Bambino, e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Woman's Health Sciences Department, Gynecologic Section, Polytechnic University of Marche, Ancona, Italy.
Eur J Surg Oncol. 2021 May;47(5):1083-1089. doi: 10.1016/j.ejso.2020.09.030. Epub 2020 Sep 28.
The aim of this study was to assess the prevalence of urinary tract involvement diagnosed on transvaginal ultrasound examination in women gynecological cancers. The diagnostic performance of transvaginal ultrasound in detecting ureteral and bladder involvement was also evaluated.
This is a multicenter prospective study. Women with gynecological cancers or recurrence undergoing ultrasound examination were included. Transvaginal ultrasound is simple and non-invasive method. Ureters, vesico-uterine septum, bladder involvement were evaluated. Sensitivity, specificity, positive predictive values (PPV), negative predictive value (NPV) of ultrasound were calculated. Surgery or imaging methods (MRI or CT scan) were considered as reference standard.
A total of 569 patients were enrolled and 547 of them had diagnosis of malignancy. 56/547 (10.2%) had a diagnosis of urinary tract infiltration at ultrasound examination. On ultrasound examination, both ureters were clearly visualized in the vast majority of cases (507/547, 92.7%), whereas only one ureter was identified in 21/547 (3.8%) patients and both ureters were not visualized in 19/547 (3.5%). Ultrasound examination demonstrated high specificity (>99.0%) and high NPV (>97.0%) for all ultrasound parameters; sensitivity was good for bladder wall infiltration (83.3%) and for vesico-uterine septum infiltration (80.8%), and low for right (69.23%) and left (65.4%) ureter infiltration.
The prevalence of pelvic urinary tract infiltration on transvaginal ultrasound examination in women with gynecologic malignancy was 10%. We believe that pelvic urinary tract assessment plays a key role during transvaginal ultrasound examination, in order to plan the management of patients with gynecologic cancers.
本研究旨在评估经阴道超声检查诊断妇科癌症患者尿路受累的患病率。还评估了经阴道超声在检测输尿管和膀胱受累方面的诊断性能。
这是一项多中心前瞻性研究。纳入接受超声检查的妇科癌症或复发患者。经阴道超声是一种简单且无创的方法。评估输尿管、膀胱-子宫隔、膀胱受累情况。计算超声的敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)。手术或影像学方法(MRI 或 CT 扫描)被认为是参考标准。
共纳入 569 例患者,其中 547 例诊断为恶性肿瘤。56/547(10.2%)例经超声检查诊断为尿路浸润。在超声检查中,绝大多数患者(507/547,92.7%)清楚地显示了两条输尿管,而在 21/547(3.8%)患者中仅识别出一条输尿管,在 19/547(3.5%)患者中两条输尿管均未显示。超声检查显示所有超声参数的特异性(>99.0%)和阴性预测值(>97.0%)均较高;对于膀胱壁浸润(83.3%)和膀胱-子宫隔浸润(80.8%),超声检查的敏感性较好,而对于右侧(69.23%)和左侧(65.4%)输尿管浸润的敏感性较低。
在妇科恶性肿瘤患者中,经阴道超声检查盆腔尿路浸润的患病率为 10%。我们认为,盆腔尿路评估在经阴道超声检查中起着关键作用,以便为妇科癌症患者的管理计划提供依据。